CD36, oxidized LDL and PPARγ: pathological interactions in macrophages and atherosclerosis
Section snippets
Relative roles of CD36 and SR-A in atherosclerosis
Endemann et al. (1993) used an expression cloning strategy to identify murine macrophage receptors that recognized OxLDL but not acetylated LDL. They identified the murine homologue of CD36 (platelet gpIV). CD36 is a member of family of receptors that also includes SR-B1/CLA-1, a HDL receptor (Acton et al., 1996, Calvo and Vega, 1993). CD36 was originally identified as a platelet membrane glycoprotein and a receptor for thrombospondin (TSP-1) (Li et al., 1993). It is also expressed by
Lipid ligands of CD36
Much interested has been focused on the components of OxLDL that are recognized by and bind to macrophage scavenger receptors. CD36 recognizes lipid moities of OxLDL. This is in contrast to SR-A, which recognizes the oxidized apoprotein portion of the lipoprotein particle (Parthasarathy et al., 1987). Several years ago, we demonstrated that delipidated 125I-labeled OxLDL did not bind to CD36-transfected cells, whereas delipidated OxLDL will bind to SR-A (Nicholson et al., 1995). Anionic
Regulation of CD36
Foam cell will not develop in macrophages cultured with high levels of native LDL because high cellular cholesterol levels down-regulate LDL-receptor gene transcription. This pathway does not inhibit scavenger receptors, but the role of lipids in regulating expression of scavenger receptors was not tested until we studied the effect of lipoproteins on the expression of CD36 in J774 cells, a murine macrophage cell line (Han et al., 1997). Exposure to OxLDL resulted in a marked induction of CD36
Effects of thiazolidinediones on CD36 and atherosclerosis
The thiazolidinedione (TZD) class of insulin sensitizing drugs is used for the treatment of type 2 diabetes. Because of the potential adverse effect of up-regulation of CD36 in response to these PPARγ agonists, it was important to determine the effects of TZDs on macrophage foam cell formation and atherosclerosis. Treatment of macrophage cell lines with troglitazone and LG268 (an RXR agonist) led to a significant increase in binding and uptake of OxLDL (Tontonoz et al., 1998). In contrast,
Effects of statins on CD36
Inhibition of scavenger receptor expression is one potential mechanism by which hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) may modulate atherosclerotic lesion formation. While inhibition of cholesterol synthesis in the liver is the primary mechanism by which statins exert their atherosclerotic effects, statins also have pleotrophic effects that are distinct from their cholesterol-lowering actions. We, and others, have shown that statins inhibit macrophage
Insulin resistance and diabetes
The role and regulation of CD36 in diabetes and insulin resistance has been addressed by several groups, but is controversial. It is clear that both microvascular and macrovascular disease are accelerated in diabetic patients. In fact, type 2 diabetics have a three-fold increased risk of developing coronary artery disease. However, the cause of accelerated atherosclerosis is poorly understood. CD36 was identified as an insulin-resistance gene causing defective fatty acid and glucose metabolism
HDL inhibits CD36 through phosphorylation of PPARγ
Because of CD36 is a potential therapeutic target for atherosclerosis, an understanding of mechanisms to inhibit or down-regulate its expression is important. LPS, dexamethasone, interferon-γ and TGF-β inhibit expression of CD36 (Yesner et al., 1996, Nakagawa et al., 1998, Han et al., 2000). We tested the hypothesis that HDL could modulate PPARγ-responsive genes by acting as a cholesterol acceptor particle. We had previously demonstrated that removal (efflux) of cholesterol with cyclodextrin (a
Acknowledgements
This work was supported by a National Institutes of Health Grant NIH P01-HL072942 (ACN and DPH). Additional support was provided by the Rosanne H. Silbermann Foundation (ACN).
References (54)
- et al.
Transcriptional activation by peroxisome proliferator-activated receptor g is inhibited by phosphorylation at a consensus mitogen-activated kinase site
J. Biol. Chem.
(1997) - et al.
The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein
J. Biol. Chem.
(2000) - et al.
Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family
J. Biol. Chem.
(1993) - et al.
Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL
J. Lipid Res.
(1998) - et al.
Regulation of peroxisome proliferator-activated receptor g activity by mitogen-activated protein kinase
J. Biol. Chem.
(1997) - et al.
Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake
J. Biol. Chem.
(1999) - et al.
CD36 is a receptor for oxidized low density lipoprotein
J. Biol. Chem.
(1993) - et al.
A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
J. Biol. Chem.
(1999) - et al.
Atorvastatin therapy in hypercholesterolomic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes
Atherosclerosis
(2002) - et al.
Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK)
J. Biol. Chem.
(1998)
Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36
J. Biol. Chem.
Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36
J. Lipid Res.
Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma
J. Biol. Chem.
Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein
J. Biol. Chem.
Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation
Blood
Identification of the molecular defects in a subject with type I CD36 deficiency
Blood
High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II
J. Biol. Chem.
Oxidized LDL regulates macrophages gene expression through ligand activation of PPARg
Cell
Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells
Biochem. Pharmacol.
Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36
J. Biol. Chem.
The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids
J. Biol. Chem.
Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes
Atherosclerosis
Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma
Curr. Opin. Genet. Dev.
PPARg promotes monocyte/macrophage differentiation and uptake of oxidized LDL
Cell
Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages
Biochim. Biophys. Acta
Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor
Science
Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
Nat. Genet.
Cited by (73)
Towards potent anti-inflammatory therapies in atherosclerosis: The case of methotrexate and colchicine combination into compartmentalized liposomes
2023, Journal of Drug Delivery Science and TechnologyDi-n-butyl phthalate modifies PMA-induced macrophage differentiation of THP-1 monocytes via PPARγ
2019, Toxicology in VitroProtective effects of bezafibrate against elaidic acid-induced accumulation of lipid droplets in monocytic cells
2017, Current Research in Translational MedicineCitation Excerpt :This observation can explain why PA did not upregulate CD36 expression, due to its inability to activate PPAR-γ. However, the high expression of CD36, produced especially with EA, indicates a high uptake of oxidized lipoproteins [61], which consequently contributes to macrophage conversion to foam cells [62]. We showed that elevated levels of EA could increase the uptake of FA in human monocytes and subsequently induce smooth cell formation, as shown by transmission electron microscopy, which could in turn accelerate the development of atherosclerotic lesions through CD36.
Indoxyl sulfate stimulates oxidized LDL uptake through up-regulation of CD36 expression in THP-1 macrophages
2014, Journal of Applied BiomedicineCitation Excerpt :ERK1/2 MAPK pathway has been shown to be involved in Ox-LDL uptake in macrophages and the development of atherosclerosis (Li et al., 2010). Previous studies have also shown that ERK1/2 MAPK pathway was involved in activation of peroxisome proliferator-activated receptor gamma (PPARγ) (Yang et al., 2010) and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) (Zipper and Mulcahy, 2000), both of which mediated the CD36 expression at the transcriptional level in macrophages (Ishii et al., 2004; Nicholson and Hajjar, 2004). Therefore we evaluated the involvement of ERK1/2 MAPK in the effect of IS on THP-1 macrophages, and we found that pretreatment of THP-1 macrophages with ERK1/2 MAPK inhibitors, PD98059 and U0126, could both cause inhibition of both CD36 expression and Ox-LDL uptake in THP-1 macrophages.
Dietary fatty acids and CD36-mediated cholesterol homeostasis: Potential mechanisms
2021, Nutrition Research Reviews